Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients

被引：0
|
作者：
Fumi Umeoka
Yoshiaki Iwasaki
Masayuki Matsumura
Akinobu Takaki
Haruhiko Kobashi
Masashi Tatsukawa
Hidenori Shiraha
Shin-ichi Fujioka
Kohsaku Sakaguchi
Yasushi Shiratori
机构：
[1] Okayama University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Dentistry,Division of Gastroenterology
[3] and Pharmaceutical Sciences,undefined
[4] The Institute for Adult Disease,undefined
[5] Asahi Life Foundation,undefined
来源：
Journal of Gastroenterology | 2006年 / 41卷
关键词：
hepatitis B virus; lamivudine; fluorescent biprobe hybridization assay; mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 701
页数：8
相关论文
共 50 条
  • [1] Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients
    Umeoka, Fumi
    Iwasaki, Yoshiaki
    Matsumura, Masayuki
    Takaki, Akinobu
    Kobashi, Haruhiko
    Tatsukawa, Masashi
    Shiraha, Hidenori
    Fujioka, Shin-ichi
    Sakaguchi, Kohsaku
    Shiratori, Yasushi
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (07) : 693 - 701
  • [2] Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection
    Shi, Ming
    Yang, Zhi-Jun
    Wang, Rong-Sheng
    Zhang, Hua
    Zhu, Ya-Fen
    Xu, Yong-Ping
    Lin, Qiu-Ye
    Jin, Li-Ji
    CLINICA CHIMICA ACTA, 2006, 373 (1-2) : 172 - 175
  • [3] Pyrosequencing for detection of lamivudine-resistant hepatitis B virus
    Lindström, A
    Odeberg, J
    Albert, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) : 4788 - 4795
  • [4] Oligonucleotide chip for detection of lamivudine-resistant hepatitis B virus
    Jang, H
    Cho, M
    Heo, J
    Kim, H
    Jun, H
    Shin, W
    Cho, B
    Park, H
    Kim, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (09) : 4181 - 4188
  • [5] Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine-resistant mutants
    Wong, VWS
    Chan, HLY
    Wong, ML
    Tam, JSL
    Leung, NWY
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (03) : 323 - 329
  • [6] Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B
    Yoshida, Shigeru
    Hige, Shuhei
    Yoshida, Miyuki
    Yamashita, Naoki
    Fujisawa, Shin-ichi
    Sato, Kaori
    Kitamura, Tadashiro
    Nishimura, Masaharu
    Chuma, Makoto
    Asaka, Masahiro
    Chiba, Hitoshi
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 59 - 64
  • [7] Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
    Liu, Chun-Jen
    Kao, Jia-Horng
    Chen, Pei-Jer
    Lai, Ming-Yang
    Chen, Ding-Shinn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A106 - A106
  • [8] Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
    Liu, C. -J.
    Kao, J. -H.
    Chen, P. -J.
    Chen, T. -C.
    Lin, F. -Y.
    Lai, M. -Y.
    Chen, D. -S.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (06) : 387 - 395
  • [9] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
    Perrillo, R
    Schiff, E
    Yoshida, E
    Statler, A
    Hirsch, K
    Wright, T
    Gutfreund, K
    Lamy, P
    Murray, A
    HEPATOLOGY, 2000, 32 (01) : 129 - 134
  • [10] Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Hirakawa, Miharu
    Kawamura, Yusuke
    Yastuji, Hiromi
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Miyakawa, Yuzo
    Kumada, Hiromitsu
    HEPATOLOGY RESEARCH, 2010, 40 (02) : 145 - 152
12345